Mellkasfali és emlo angiosarcoma sugárkezelés után: A radiogén eredet, a diagnózis és a kezelés kérdései

Translated title of the contribution: Angiosarcomas of the chest wall and breast after radiotherapy: The questions of radiogenic origin, diagnosis and treatment

Csaba Polgár, Zsolt Orosz, Andrea Szerdahelyi, János Fodor, Anikó Mágori, Ferenc Czeyda-Pommersheim, István Vámosi Nagy, István Szakolczai, Zsuzsanna Fejos, György Németh

Research output: Contribution to journalArticle

Abstract

Purpose: To present medical history of secondary chest wall and breast angiosarcomas (AS) developed after radiotherapy, and to discuss the questions of radiogenic origin, diagnosis and treatment by the review of the literature. Methods: Report of two cases and MEDLINE search for relevant publications. Results: Secondary AS occured in a previously irradiated field after a long (6 and 8 years) latency period in both cases. Detailed histopathological and immunohistochemical examinations from the biopsy and/or surgical specimens confirmed the diagnosis as AS. The first patient with moderately differentiated AS was treated successfully with radical surgery. The second patient with irresecable AS died of rapid local progression within 4 months. The incidence of chest wall and breast AS is increased after irradiation, however, controversial data exist in the literature. The incidence of chest wall and breast AS after radiotherapy was found to be 0.39% in our patient population, which means an estimated odds ratio of 2.4 for secondary AS. Stewart-Treves syndrome is not of radiogenic origin, since postoperative lymphoedema has been considered as primary etiological factor. Conclusions: Patients treated with surgery and/or radiotherapy for primary breast cancer are at higher risk for developing secondary AS, compared to the healthy population. An etiological relationship between radiotherapy and subsequent AS of chest wall and breast is likely, but still controversial. Initial radical surgery is the only effective treatment for achieving long term survival. Further adjuvant radiotherapy is no longer feasible, due to the previous irradiation. Chemotherapy has only palliative effect. These very rare cases deserve special attention due to the atypical clinical appearance, difficulties of differential diagnosis and poor prognosis.

Original languageHungarian
Pages (from-to)135-139
Number of pages5
JournalMagyar onkologia
Volume44
Issue number2
Publication statusPublished - Dec 1 2000

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Polgár, C., Orosz, Z., Szerdahelyi, A., Fodor, J., Mágori, A., Czeyda-Pommersheim, F., Vámosi Nagy, I., Szakolczai, I., Fejos, Z., & Németh, G. (2000). Mellkasfali és emlo angiosarcoma sugárkezelés után: A radiogén eredet, a diagnózis és a kezelés kérdései. Magyar onkologia, 44(2), 135-139.